US20180251793A1

US20180251793A1 - Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription

Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription Download PDF

Info

Publication number: US20180251793A1
Authority: US; United States
Prior art keywords: dna; rna; site; cell; activity
Prior art date: 2012-05-25
Legal status : Pending

Application number

US15/981,807

Inventor

Jennifer A. DOUDNA

Martin Jinek

Krzysztof Chylinski

Emmanuelle Charpentier

Current Assignee

Universitaet Wien

University of California

Original Assignee

Universitaet Wien

University of California

Priority date

2012-05-25

Filing date

2018-05-16

Publication date

2018-09-06

Family has litigation

Priority claimed from US201261652086P external-priority

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49624232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20180251793(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-05-16 Application filed by Universitaet Wien, University of California filed Critical Universitaet Wien

2018-05-16 Priority to US15/981,807 priority Critical patent/US20180251793A1/en

2018-05-18 Assigned to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA reassignment THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JINEK, MARTIN, DOUDNA, JENNIFER A., DOUDNA CATE, James Harrison, LIM, WENDELL A., QI, Lei S.

2018-05-18 Assigned to UNIVERSITY OF VIENNA reassignment UNIVERSITY OF VIENNA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHYLINSKI, Krzysztof

2018-09-06 Publication of US20180251793A1 publication Critical patent/US20180251793A1/en

Status Pending legal-status Critical Current

Links

230000000051 modifying Effects 0.000 title claims abstract description 421
230000035897 transcription Effects 0.000 title claims abstract description 83
239000000203 mixture Substances 0.000 title abstract description 87
230000008836 DNA modification Effects 0.000 title description 3
229920000160 (ribonucleotides)n+m Polymers 0.000 claims abstract description 603
108010082319 CRISPR-Associated Protein 9 Proteins 0.000 claims abstract description 198
150000007523 nucleic acids Chemical class 0.000 claims abstract description 196
108020004707 nucleic acids Proteins 0.000 claims abstract description 182
230000004048 modification Effects 0.000 claims abstract description 49
238000006011 modification reaction Methods 0.000 claims abstract description 49
241000282414 Homo sapiens Species 0.000 claims abstract description 43
229920003013 deoxyribonucleic acid Polymers 0.000 claims abstract description 29
210000004027 cells Anatomy 0.000 claims description 476
229920001850 Nucleic acid sequence Polymers 0.000 claims description 230
229920000023 polynucleotide Polymers 0.000 claims description 180
239000002157 polynucleotide Substances 0.000 claims description 180
239000002773 nucleotide Substances 0.000 claims description 122
125000003729 nucleotide group Chemical group 0.000 claims description 121
125000003275 alpha amino acid group Chemical group 0.000 claims description 91
102000004169 proteins and genes Human genes 0.000 claims description 65
108090000623 proteins and genes Proteins 0.000 claims description 65
210000003527 eukaryotic cell Anatomy 0.000 claims description 54
150000001413 amino acids Chemical class 0.000 claims description 48
230000036678 protein binding Effects 0.000 claims description 44
230000035772 mutation Effects 0.000 claims description 42
-1 nimal Species 0.000 claims description 33
230000003612 virological Effects 0.000 claims description 23
210000004962 mammalian cells Anatomy 0.000 claims description 15
239000012528 membrane Substances 0.000 claims description 9
230000001177 retroviral Effects 0.000 claims description 8
208000009889 Herpes Simplex Diseases 0.000 claims description 7
241000700584 Simplexvirus Species 0.000 claims description 7
108020004461 Double-Stranded RNA Proteins 0.000 claims description 6
210000003463 Organelles Anatomy 0.000 claims description 6
238000010361 transduction Methods 0.000 claims description 6
230000026683 transduction Effects 0.000 claims description 6
229920001184 polypeptide Polymers 0.000 abstract description 563
229920000033 CRISPR Polymers 0.000 abstract description 182
230000000694 effects Effects 0.000 description 366
230000000295 complement Effects 0.000 description 123
108091006028 chimera Proteins 0.000 description 116
101710010743 CSN1S1 Proteins 0.000 description 70
101710035129 GPS1 Proteins 0.000 description 70
230000002255 enzymatic Effects 0.000 description 70
230000014509 gene expression Effects 0.000 description 64
235000018102 proteins Nutrition 0.000 description 60
230000004570 RNA-binding Effects 0.000 description 54
235000001014 amino acid Nutrition 0.000 description 53
230000000875 corresponding Effects 0.000 description 46
238000003776 cleavage reaction Methods 0.000 description 45
101700080605 NUC1 Proteins 0.000 description 44
101700006494 nucA Proteins 0.000 description 44
210000000130 stem cell Anatomy 0.000 description 40
229920005681 CRISPR RNA Polymers 0.000 description 33
230000001105 regulatory Effects 0.000 description 32
238000000338 in vitro Methods 0.000 description 30
238000003259 recombinant expression Methods 0.000 description 28
230000001580 bacterial Effects 0.000 description 26
239000003153 chemical reaction reagent Substances 0.000 description 25
230000001939 inductive effect Effects 0.000 description 25
230000027455 binding Effects 0.000 description 24
150000001875 compounds Chemical class 0.000 description 24
241000894007 species Species 0.000 description 23
201000010099 disease Diseases 0.000 description 22
239000003814 drug Substances 0.000 description 21
235000003869 genetically modified organisms (GMOs) Nutrition 0.000 description 21
230000002708 enhancing Effects 0.000 description 20
230000001225 therapeutic Effects 0.000 description 20
229920000272 Oligonucleotide Polymers 0.000 description 19
241000193996 Streptococcus pyogenes Species 0.000 description 19
230000000670 limiting Effects 0.000 description 18
230000001404 mediated Effects 0.000 description 18
238000001890 transfection Methods 0.000 description 18
241000196324 Embryophyta Species 0.000 description 17
230000035492 administration Effects 0.000 description 17
108009000261 Non-homologous end joining Proteins 0.000 description 16
108060003434 alpha Proteins 0.000 description 16
230000004927 fusion Effects 0.000 description 16
210000001778 pluripotent stem cell Anatomy 0.000 description 16
235000000346 sugar Nutrition 0.000 description 16
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 15
230000034431 double-strand break repair via homologous recombination Effects 0.000 description 15
229940079593 drugs Drugs 0.000 description 15
210000004602 germ cell Anatomy 0.000 description 15
238000000034 method Methods 0.000 description 15
210000001519 tissues Anatomy 0.000 description 15
101700064880 MBD2 Proteins 0.000 description 14
102100008691 MBD2 Human genes 0.000 description 14
238000003780 insertion Methods 0.000 description 14
229920001405 Coding region Polymers 0.000 description 13
241000699666 Mus <mouse, genus> Species 0.000 description 13
241000283984 Rodentia Species 0.000 description 13
241000251539 Vertebrata <Metazoa> Species 0.000 description 13
239000003795 chemical substances by application Substances 0.000 description 13
125000005647 linker group Chemical group 0.000 description 13
238000011160 research Methods 0.000 description 13
210000001082 somatic cell Anatomy 0.000 description 13
229920002395 Aptamer Polymers 0.000 description 12
102000001253 Protein Kinases Human genes 0.000 description 12
241000700605 Viruses Species 0.000 description 12
UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
238000009396 hybridization Methods 0.000 description 12
238000004519 manufacturing process Methods 0.000 description 12
239000000243 solution Substances 0.000 description 12
238000006467 substitution reaction Methods 0.000 description 12
102200028136 CSN1S1 D10A Human genes 0.000 description 11
210000001671 Embryonic Stem Cells Anatomy 0.000 description 11
108091000081 Phosphotransferases Proteins 0.000 description 11
239000000463 material Substances 0.000 description 11
230000011987 methylation Effects 0.000 description 11
238000007069 methylation reaction Methods 0.000 description 11
210000001236 prokaryotic cell Anatomy 0.000 description 11
238000005215 recombination Methods 0.000 description 11
230000002829 reduced Effects 0.000 description 11
241000701022 Cytomegalovirus Species 0.000 description 10
241000124008 Mammalia Species 0.000 description 10
101700007524 PTD Proteins 0.000 description 10
101700061430 SAT19 Proteins 0.000 description 10
101710043164 Segment-4 Proteins 0.000 description 10
101700081234 TTR Proteins 0.000 description 10
101700038759 VP1 Proteins 0.000 description 10
101700005460 hemA Proteins 0.000 description 10
239000000185 hemagglutinin Substances 0.000 description 10
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 10
210000002569 neurons Anatomy 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
238000003786 synthesis reaction Methods 0.000 description 10
CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 9
241000251468 Actinopterygii Species 0.000 description 9
210000001218 Blood-Brain Barrier Anatomy 0.000 description 9
210000000349 Chromosomes Anatomy 0.000 description 9
229920002676 Complementary DNA Polymers 0.000 description 9
102000033180 ERVK-6 Human genes 0.000 description 9
108010043121 Green Fluorescent Proteins Proteins 0.000 description 9
102000004144 Green Fluorescent Proteins Human genes 0.000 description 9
150000001408 amides Chemical class 0.000 description 9
210000004102 animal cell Anatomy 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 9
239000003623 enhancer Substances 0.000 description 9
235000019688 fish Nutrition 0.000 description 9
230000002068 genetic Effects 0.000 description 9
238000010353 genetic engineering Methods 0.000 description 9
239000005090 green fluorescent protein Substances 0.000 description 9
125000000623 heterocyclic group Chemical group 0.000 description 9
239000007924 injection Substances 0.000 description 9
239000002777 nucleoside Substances 0.000 description 9
239000008194 pharmaceutical composition Substances 0.000 description 9
238000010446 CRISPR interference Methods 0.000 description 8
229920002168 Chimeric RNA Polymers 0.000 description 8
231100000277 DNA damage Toxicity 0.000 description 8
230000033616 DNA repair Effects 0.000 description 8
210000001161 Embryo, Mammalian Anatomy 0.000 description 8
102000004533 Endonucleases Human genes 0.000 description 8
108010042407 Endonucleases Proteins 0.000 description 8
UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
229920002391 Guide RNA Polymers 0.000 description 8
210000004263 Induced Pluripotent Stem Cells Anatomy 0.000 description 8
210000004940 Nucleus Anatomy 0.000 description 8
229920002224 Peptide nucleic acid Polymers 0.000 description 8
241000700159 Rattus Species 0.000 description 8
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 8
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 8
238000006640 acetylation reaction Methods 0.000 description 8
235000004279 alanine Nutrition 0.000 description 8
238000010790 dilution Methods 0.000 description 8
230000001965 increased Effects 0.000 description 8
238000002347 injection Methods 0.000 description 8
230000003993 interaction Effects 0.000 description 8
239000002609 media Substances 0.000 description 8
239000002245 particle Substances 0.000 description 8
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
230000002194 synthesizing Effects 0.000 description 8
230000001131 transforming Effects 0.000 description 8
210000003763 Chloroplasts Anatomy 0.000 description 7
229940035893 Uracil Drugs 0.000 description 7
125000000217 alkyl group Chemical group 0.000 description 7
230000001413 cellular Effects 0.000 description 7
230000021615 conjugation Effects 0.000 description 7
239000003599 detergent Substances 0.000 description 7
230000012010 growth Effects 0.000 description 7
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
238000004806 packaging method and process Methods 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
241001430294 unidentified retrovirus Species 0.000 description 7
101710036216 ATEG_03556 Proteins 0.000 description 6
229960000643 Adenine Drugs 0.000 description 6
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Natural products NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 6
241000432074 Adeno-associated virus Species 0.000 description 6
241000283690 Bos taurus Species 0.000 description 6
108020004705 Codon Proteins 0.000 description 6
229940104302 Cytosine Drugs 0.000 description 6
OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
108010046331 Deoxyribodipyrimidine Photo-Lyase Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
241000725303 Human immunodeficiency virus Species 0.000 description 6
108010061833 Integrases Proteins 0.000 description 6
102000003960 Ligases Human genes 0.000 description 6
108090000364 Ligases Proteins 0.000 description 6
241000186805 Listeria innocua Species 0.000 description 6
229920002521 Macromolecule Polymers 0.000 description 6
TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
101710003000 ORF1/ORF2 Proteins 0.000 description 6
101700030467 Pol Proteins 0.000 description 6
229920002873 Polyethylenimine Polymers 0.000 description 6
229920002291 Pyrimidine dimer Polymers 0.000 description 6
102000018120 Recombinases Human genes 0.000 description 6
108010091086 Recombinases Proteins 0.000 description 6
240000004808 Saccharomyces cerevisiae Species 0.000 description 6
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
210000002966 Serum Anatomy 0.000 description 6
229940076156 Streptococcus pyogenes Drugs 0.000 description 6
RWQNBRDOKXIBIV-UHFFFAOYSA-N Thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
102000008579 Transposases Human genes 0.000 description 6
108010020764 Transposases Proteins 0.000 description 6
QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
238000005804 alkylation reaction Methods 0.000 description 6
125000000539 amino acid group Chemical group 0.000 description 6
239000001506 calcium phosphate Substances 0.000 description 6
229910000389 calcium phosphate Inorganic materials 0.000 description 6
235000011010 calcium phosphates Nutrition 0.000 description 6
239000000969 carrier Substances 0.000 description 6
238000006481 deamination reaction Methods 0.000 description 6
230000027832 depurination Effects 0.000 description 6
102000015694 estrogen receptors Human genes 0.000 description 6
108010038795 estrogen receptors Proteins 0.000 description 6
239000003102 growth factor Substances 0.000 description 6
239000002502 liposome Substances 0.000 description 6
238000000520 microinjection Methods 0.000 description 6
230000011278 mitosis Effects 0.000 description 6
230000003647 oxidation Effects 0.000 description 6
238000007254 oxidation reaction Methods 0.000 description 6
WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
238000001556 precipitation Methods 0.000 description 6
238000000746 purification Methods 0.000 description 6
101710004466 rgy Proteins 0.000 description 6
101710030364 rgy1 Proteins 0.000 description 6
101710030359 rgy2 Proteins 0.000 description 6
150000003839 salts Chemical class 0.000 description 6
230000002103 transcriptional Effects 0.000 description 6
241000701161 unidentified adenovirus Species 0.000 description 6
241000283707 Capra Species 0.000 description 5
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 5
UHDGCWIWMRVCDJ-XVFCMESISA-N Cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-XVFCMESISA-N 0.000 description 5
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
210000002304 ESC Anatomy 0.000 description 5
JKMHFZQWWAIEOD-UHFFFAOYSA-N HEPES Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
210000003205 Muscles Anatomy 0.000 description 5
241000714474 Rous sarcoma virus Species 0.000 description 5
OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 5
229960002180 Tetracycline Drugs 0.000 description 5
239000004098 Tetracycline Substances 0.000 description 5
230000000692 anti-sense Effects 0.000 description 5
230000002759 chromosomal Effects 0.000 description 5
239000002299 complementary DNA Substances 0.000 description 5
239000000356 contaminant Substances 0.000 description 5
230000003247 decreasing Effects 0.000 description 5
230000001419 dependent Effects 0.000 description 5
238000011161 development Methods 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
239000003085 diluting agent Substances 0.000 description 5
201000009910 diseases by infectious agent Diseases 0.000 description 5
238000004520 electroporation Methods 0.000 description 5
102000034387 fluorescent proteins Human genes 0.000 description 5
108091006031 fluorescent proteins Proteins 0.000 description 5
150000002243 furanoses Chemical group 0.000 description 5
238000001415 gene therapy Methods 0.000 description 5
229910052751 metal Inorganic materials 0.000 description 5
239000002184 metal Substances 0.000 description 5
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 5
125000003835 nucleoside group Chemical group 0.000 description 5
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
108090000765 processed proteins & peptides Proteins 0.000 description 5
238000000926 separation method Methods 0.000 description 5
125000001424 substituent group Chemical group 0.000 description 5
230000004083 survival Effects 0.000 description 5
235000019364 tetracycline Nutrition 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
231100000419 toxicity Toxicity 0.000 description 5
230000001988 toxicity Effects 0.000 description 5
102000003995 transcription factors Human genes 0.000 description 5
108090000464 transcription factors Proteins 0.000 description 5
239000003981 vehicle Substances 0.000 description 5
UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
YNLCVAQJIKOXER-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]propane-1-sulfonic acid Chemical compound OCC(CO)(CO)NCCCS(O)(=O)=O YNLCVAQJIKOXER-UHFFFAOYSA-N 0.000 description 4
241000269328 Amphibia Species 0.000 description 4
241000713826 Avian leukosis virus Species 0.000 description 4
238000010453 CRISPR/Cas method Methods 0.000 description 4
JCAIWDXKLCEQEO-LXOWHHAPSA-N Copalyl diphosphate Natural products [P@@](=O)(OP(=O)(O)O)(OC/C=C(\CC[C@H]1C(=C)CC[C@H]2C(C)(C)CCC[C@@]12C)/C)O JCAIWDXKLCEQEO-LXOWHHAPSA-N 0.000 description 4
210000001900 Endoderm Anatomy 0.000 description 4
239000007995 HEPES buffer Substances 0.000 description 4
241000282412 Homo Species 0.000 description 4
241000713666 Lentivirus Species 0.000 description 4
DVLFYONBTKHTER-UHFFFAOYSA-N MOPS Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 4
210000003716 Mesoderm Anatomy 0.000 description 4
210000003470 Mitochondria Anatomy 0.000 description 4
210000004413 Myocytes, Cardiac Anatomy 0.000 description 4
108010077850 Nuclear Localization Signals Proteins 0.000 description 4
241000283898 Ovis Species 0.000 description 4
108020004422 Riboswitch Proteins 0.000 description 4
241000282898 Sus scrofa Species 0.000 description 4
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
125000000304 alkynyl group Chemical group 0.000 description 4
235000009697 arginine Nutrition 0.000 description 4
125000000511 arginine group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 4
239000006172 buffering agent Substances 0.000 description 4
210000002317 cardiac myocyte Anatomy 0.000 description 4
230000015556 catabolic process Effects 0.000 description 4
230000004059 degradation Effects 0.000 description 4
238000006731 degradation reaction Methods 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
230000005017 genetic modification Effects 0.000 description 4
235000013617 genetically modified food Nutrition 0.000 description 4
230000003899 glycosylation Effects 0.000 description 4
238000006206 glycosylation reaction Methods 0.000 description 4
235000014304 histidine Nutrition 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
238000001638 lipofection Methods 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000003550 marker Substances 0.000 description 4
230000021121 meiosis Effects 0.000 description 4
230000003278 mimic Effects 0.000 description 4
239000002105 nanoparticle Substances 0.000 description 4
150000003833 nucleoside derivatives Chemical class 0.000 description 4
210000000287 oocyte Anatomy 0.000 description 4
150000004713 phosphodiesters Chemical class 0.000 description 4
125000004437 phosphorous atoms Chemical group 0.000 description 4
229910052698 phosphorus Inorganic materials 0.000 description 4
230000035939 shock Effects 0.000 description 4
230000001743 silencing Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
230000000087 stabilizing Effects 0.000 description 4
150000003431 steroids Chemical class 0.000 description 4
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical class [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
239000011534 wash buffer Substances 0.000 description 4
108091005946 yellow fluorescent protein Proteins 0.000 description 4
XUNKPNYCNUKOAU-VXJRNSOOSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]a Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XUNKPNYCNUKOAU-VXJRNSOOSA-N 0.000 description 3
VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dimercaptobutane-2,3-diol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 3
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-Methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
229940009098 Aspartate Drugs 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
210000002459 Blastocyst Anatomy 0.000 description 3
210000004556 Brain Anatomy 0.000 description 3
206010006187 Breast cancer Diseases 0.000 description 3
HVYWMOMLDIMFJA-DPAQBDIFSA-N Cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
241000243321 Cnidaria Species 0.000 description 3
CKLJMWTZIZZHCS-UHFFFAOYSA-N DL-aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 3
230000007067 DNA methylation Effects 0.000 description 3
230000004568 DNA-binding Effects 0.000 description 3
241000252212 Danio rerio Species 0.000 description 3
229920002307 Dextran Polymers 0.000 description 3
210000003981 Ectoderm Anatomy 0.000 description 3
241000991587 Enterovirus C Species 0.000 description 3
229960002743 Glutamine Drugs 0.000 description 3
241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
210000004072 Lung Anatomy 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
239000007987 MES buffer Substances 0.000 description 3
239000007993 MOPS buffer Substances 0.000 description 3
101700075357 MYC Proteins 0.000 description 3
241000714177 Murine leukemia virus Species 0.000 description 3
241000202964 Mycoplasma mobile Species 0.000 description 3
241000713883 Myeloproliferative sarcoma virus Species 0.000 description 3
241000588650 Neisseria meningitidis Species 0.000 description 3
108091005503 Nucleic proteins Proteins 0.000 description 3
241000606856 Pasteurella multocida Species 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
241000288906 Primates Species 0.000 description 3
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
102100016799 RBP3 Human genes 0.000 description 3
230000025458 RNA interference Effects 0.000 description 3
206010039491 Sarcoma Diseases 0.000 description 3
241000713896 Spleen necrosis virus Species 0.000 description 3
241000194019 Streptococcus mutans Species 0.000 description 3
229940113082 Thymine Drugs 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
241000700618 Vaccinia virus Species 0.000 description 3
239000002253 acid Substances 0.000 description 3
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 3
125000003342 alkenyl group Chemical group 0.000 description 3
230000001775 anti-pathogenic Effects 0.000 description 3
230000000840 anti-viral Effects 0.000 description 3
239000002246 antineoplastic agent Substances 0.000 description 3
230000003115 biocidal Effects 0.000 description 3
230000033228 biological regulation Effects 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
230000000747 cardiac effect Effects 0.000 description 3
230000003197 catalytic Effects 0.000 description 3
230000024881 catalytic activity Effects 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
230000001605 fetal Effects 0.000 description 3
239000012530 fluid Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
108010048996 interstitial retinol-binding protein Proteins 0.000 description 3
239000006166 lysate Substances 0.000 description 3
235000018977 lysine Nutrition 0.000 description 3
229910001629 magnesium chloride Inorganic materials 0.000 description 3
229910052943 magnesium sulfate Inorganic materials 0.000 description 3
CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
201000009906 meningitis Diseases 0.000 description 3
230000002438 mitochondrial Effects 0.000 description 3
230000000394 mitotic Effects 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
238000002887 multiple sequence alignment Methods 0.000 description 3
230000003000 nontoxic Effects 0.000 description 3
231100000252 nontoxic Toxicity 0.000 description 3
230000003285 pharmacodynamic Effects 0.000 description 3
230000000275 pharmacokinetic Effects 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
229920000724 poly(L-arginine) polymer Polymers 0.000 description 3
229920000768 polyamine Polymers 0.000 description 3
108010011110 polyarginine Proteins 0.000 description 3
238000003752 polymerase chain reaction Methods 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
239000001103 potassium chloride Substances 0.000 description 3
235000011164 potassium chloride Nutrition 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
230000001737 promoting Effects 0.000 description 3
230000004952 protein activity Effects 0.000 description 3
210000001938 protoplasts Anatomy 0.000 description 3
230000001718 repressive Effects 0.000 description 3
230000002987 rna-interference Effects 0.000 description 3
150000003384 small molecules Chemical class 0.000 description 3
IRHWMYKYLWNHTL-UHFFFAOYSA-M sodium 2-(N-morpholino)ethanesulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCN1CCOCC1 IRHWMYKYLWNHTL-UHFFFAOYSA-M 0.000 description 3
239000002904 solvent Substances 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
239000000758 substrate Substances 0.000 description 3
108010082953 tat peptide (47-57), Human immunodeficiency virus 1 Proteins 0.000 description 3
150000003568 thioethers Chemical class 0.000 description 3
230000005026 transcription initiation Effects 0.000 description 3
108091006090 transcriptional activators Proteins 0.000 description 3
230000032258 transport Effects 0.000 description 3
241001515965 unidentified phage Species 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
MSSXOMSJDRHRMC-UHFFFAOYSA-N 2,6-Diaminopurine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 2
PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical group NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 2
SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholino)ethanesulfonic acid Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
PEHVGBZKEYRQSX-UHFFFAOYSA-N 7H-pyrrolo[2,3-d]pyrimidin-4-amine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
229940064005 Antibiotic throat preparations Drugs 0.000 description 2
229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
229940042052 Antibiotics for systemic use Drugs 0.000 description 2
229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
241000203069 Archaea Species 0.000 description 2
241000218495 Bactrocera correcta Species 0.000 description 2
241001536303 Botryococcus braunii Species 0.000 description 2
241000282465 Canis Species 0.000 description 2
210000000234 Capsid Anatomy 0.000 description 2
UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
210000000170 Cell Membrane Anatomy 0.000 description 2
210000003169 Central Nervous System Anatomy 0.000 description 2
241000195597 Chlamydomonas reinhardtii Species 0.000 description 2
235000007091 Chlorella pyrenoidosa Nutrition 0.000 description 2
240000009108 Chlorella vulgaris Species 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
150000008574 D-amino acids Chemical class 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N DEOXYTHYMIDINE Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102000031025 DNA-Binding Proteins Human genes 0.000 description 2
108091000102 DNA-Binding Proteins Proteins 0.000 description 2
108010008532 Deoxyribonuclease I Proteins 0.000 description 2
102000007260 Deoxyribonuclease I Human genes 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
101700070897 ENO2 Proteins 0.000 description 2
102100003738 ENO2 Human genes 0.000 description 2
101710038044 ERVK-6 Proteins 0.000 description 2
101710027967 ERVW-1 Proteins 0.000 description 2
241000258955 Echinodermata Species 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
229920001272 Exogenous DNA Polymers 0.000 description 2
101700018827 FOXD3 Proteins 0.000 description 2
241000282324 Felis Species 0.000 description 2
241000233866 Fungi Species 0.000 description 2
210000001654 Germ Layers Anatomy 0.000 description 2
108020005004 Guide RNA Proteins 0.000 description 2
229940093922 Gynecological Antibiotics Drugs 0.000 description 2
102000003893 Histone Acetyltransferases Human genes 0.000 description 2
108090000246 Histone Acetyltransferases Proteins 0.000 description 2
102000008157 Histone Demethylases Human genes 0.000 description 2
108010074870 Histone Demethylases Proteins 0.000 description 2
108010033040 Histones Proteins 0.000 description 2
102000006947 Histones Human genes 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N Hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
206010022114 Injury Diseases 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
241000589242 Legionella pneumophila Species 0.000 description 2
241000270322 Lepidosauria Species 0.000 description 2
101710033910 MT-I Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
108020004388 MicroRNAs Proteins 0.000 description 2
210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 2
102000015528 Myelin Basic Protein Human genes 0.000 description 2
108010025255 Myelin Basic Protein Proteins 0.000 description 2
241001250129 Nannochloropsis gaditana Species 0.000 description 2
241000244206 Nematoda Species 0.000 description 2
210000000496 Pancreas Anatomy 0.000 description 2
229940049954 Penicillin Drugs 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
LLKYUHGUYSLMPA-UHFFFAOYSA-N Phosphoramidite Chemical compound NP([O-])[O-] LLKYUHGUYSLMPA-UHFFFAOYSA-N 0.000 description 2
229920000795 Polyadenylation Polymers 0.000 description 2
108020004412 RNA 3' Polyadenylation Signals Proteins 0.000 description 2
239000007759 RPMI Media 1640 Substances 0.000 description 2
229920000970 Repeated sequence (DNA) Polymers 0.000 description 2
101700006931 SOX2 Proteins 0.000 description 2
101710026013 SPCC1281.06c Proteins 0.000 description 2
241000593524 Sargassum patens Species 0.000 description 2
101710023234 Segment 5 Proteins 0.000 description 2
108020004459 Small Interfering RNA Proteins 0.000 description 2
229920000978 Start codon Polymers 0.000 description 2
229960005322 Streptomycin Drugs 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine Kinase Proteins 0.000 description 2
229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
229920001949 Transfer RNA Polymers 0.000 description 2
108020004566 Transfer RNA Proteins 0.000 description 2
108020004417 Untranslated RNA Proteins 0.000 description 2
101700028070 VPX Proteins 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N Xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000003213 activating Effects 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
210000001789 adipocyte Anatomy 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000000240 adjuvant Effects 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
108010003152 bacteriophage T7 RNA polymerase Proteins 0.000 description 2
239000003855 balanced salt solution Substances 0.000 description 2
229960000626 benzylpenicillin Drugs 0.000 description 2
230000031018 biological processes and functions Effects 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
125000004432 carbon atoms Chemical group C* 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
230000011088 chloroplast localization Effects 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
210000004748 cultured cells Anatomy 0.000 description 2
125000000753 cycloalkyl group Chemical group 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
238000007865 diluting Methods 0.000 description 2
230000035510 distribution Effects 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
239000000975 dye Substances 0.000 description 2
230000004049 epigenetic modification Effects 0.000 description 2
230000003203 everyday Effects 0.000 description 2
238000005755 formation reaction Methods 0.000 description 2
238000007710 freezing Methods 0.000 description 2
230000002538 fungal Effects 0.000 description 2
238000010363 gene targeting Methods 0.000 description 2
238000010358 genetic engineering technique Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
239000001963 growth media Substances 0.000 description 2
230000003781 hair follicle cycle Effects 0.000 description 2
125000001475 halogen functional group Chemical group 0.000 description 2
125000005842 heteroatoms Chemical group 0.000 description 2
230000001976 improved Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229940079866 intestinal antibiotics Drugs 0.000 description 2
238000007913 intrathecal administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl β-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
108060004795 methyltransferase family Proteins 0.000 description 2
102000016397 methyltransferase family Human genes 0.000 description 2
229920001239 microRNA Polymers 0.000 description 2
239000002679 microRNA Substances 0.000 description 2
230000025608 mitochondrion localization Effects 0.000 description 2
230000001537 neural Effects 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108010054543 nonaarginine Proteins 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
238000005457 optimization Methods 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
150000008298 phosphoramidates Chemical class 0.000 description 2
238000006366 phosphorylation reaction Methods 0.000 description 2
230000000865 phosphorylative Effects 0.000 description 2
230000004962 physiological condition Effects 0.000 description 2
230000001402 polyadenylating Effects 0.000 description 2
229920000447 polyanionic polymer Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
239000011591 potassium Substances 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
230000002633 protecting Effects 0.000 description 2
108020001580 protein domains Proteins 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
239000003638 reducing agent Substances 0.000 description 2
230000000754 repressing Effects 0.000 description 2
229920002973 ribosomal RNA Polymers 0.000 description 2
101700066061 scd1 Proteins 0.000 description 2
239000002924 silencing RNA Substances 0.000 description 2
KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
238000003860 storage Methods 0.000 description 2
230000004960 subcellular localization Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
108010038756 tat Gene Products Proteins 0.000 description 2
102000015609 tat Gene Products Human genes 0.000 description 2
238000010257 thawing Methods 0.000 description 2
150000003573 thiols Chemical class 0.000 description 2
230000005029 transcription elongation Effects 0.000 description 2
108091006091 transcriptional repressors Proteins 0.000 description 2
230000031998 transcytosis Effects 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
102000027575 transmembrane receptors Human genes 0.000 description 2
108091007901 transmembrane receptors Proteins 0.000 description 2
238000010798 ubiquitination Methods 0.000 description 2
239000004474 valine Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
BEJKOYIMCGMNRB-GRHHLOCNSA-N (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
LAQPKDLYOBZWBT-NYLDSJSYSA-N (2S,4S,5R,6R)-5-acetamido-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3R,4R,5R)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1R,2R)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
QGVQZRDQPDLHHV-DPAQBDIFSA-N (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-thiol Chemical compound C1C=C2C[C@@H](S)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QGVQZRDQPDLHHV-DPAQBDIFSA-N 0.000 description 1
UFSCXDAOCAIFOG-UHFFFAOYSA-N 1,10-dihydropyrimido[5,4-b][1,4]benzothiazin-2-one Chemical compound S1C2=CC=CC=C2N=C2C1=CNC(=O)N2 UFSCXDAOCAIFOG-UHFFFAOYSA-N 0.000 description 1
PTFYZDMJTFMPQW-UHFFFAOYSA-N 1,10-dihydropyrimido[5,4-b][1,4]benzoxazin-2-one Chemical compound O1C2=CC=CC=C2N=C2C1=CNC(=O)N2 PTFYZDMJTFMPQW-UHFFFAOYSA-N 0.000 description 1
FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
UHUHBFMZVCOEOV-UHFFFAOYSA-N 1H-imidazo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
IVCGJOSPVGENCT-UHFFFAOYSA-N 1H-pyrrolo[2,3-f]quinoline Chemical compound N1=CC=CC2=C(NC=C3)C3=CC=C21 IVCGJOSPVGENCT-UHFFFAOYSA-N 0.000 description 1
QSHACTSJHMKXTE-UHFFFAOYSA-N 2-(2-aminopropyl)-7H-purin-6-amine Chemical compound CC(N)CC1=NC(N)=C2NC=NC2=N1 QSHACTSJHMKXTE-UHFFFAOYSA-N 0.000 description 1
JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
WKMPTBDYDNUJLF-UHFFFAOYSA-N 2-fluoroadenine Chemical compound NC1=NC(F)=NC2=C1N=CN2 WKMPTBDYDNUJLF-UHFFFAOYSA-N 0.000 description 1
FZWGECJQACGGTI-UHFFFAOYSA-N 2-imino-7-methyl-1,2,3,7-tetrahydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
PDBUTMYDZLUVCP-UHFFFAOYSA-N 3,4-dihydro-1,4-benzoxazin-2-one Chemical compound C1=CC=C2OC(=O)CNC2=C1 PDBUTMYDZLUVCP-UHFFFAOYSA-N 0.000 description 1
125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1H-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 1
RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-Hydroxymethylcytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 1
102000037085 5-hydroxytryptamine receptor family Human genes 0.000 description 1
108091019276 5-hydroxytryptamine receptor family Proteins 0.000 description 1
ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1H-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1H-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical compound O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1H-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
QNNARSZPGNJZIX-UHFFFAOYSA-N 6-amino-5-prop-1-ynyl-1H-pyrimidin-2-one Chemical compound CC#CC1=CNC(=O)N=C1N QNNARSZPGNJZIX-UHFFFAOYSA-N 0.000 description 1
LOSIULRWFAEMFL-UHFFFAOYSA-N 7-Deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical compound C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 1
HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical compound NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
101700000555 ACP3 Proteins 0.000 description 1
102100003649 ACP3 Human genes 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
235000006491 Acacia senegal Nutrition 0.000 description 1
241001134630 Acidothermus cellulolyticus Species 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N Acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
102000011690 Adiponectin Human genes 0.000 description 1
108010076365 Adiponectin Proteins 0.000 description 1
210000004504 Adult Stem Cells Anatomy 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
108020005098 Anticodon Proteins 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
229960001230 Asparagine Drugs 0.000 description 1
BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
108060001001 BRK1 Proteins 0.000 description 1
241000606124 Bacteroides fragilis Species 0.000 description 1
241000186016 Bifidobacterium bifidum Species 0.000 description 1
241000186020 Bifidobacterium dentium Species 0.000 description 1
210000004369 Blood Anatomy 0.000 description 1
210000000601 Blood Cells Anatomy 0.000 description 1
210000001772 Blood Platelets Anatomy 0.000 description 1
210000004204 Blood Vessels Anatomy 0.000 description 1
210000001185 Bone Marrow Anatomy 0.000 description 1
QXZGBUJJYSLZLT-FDISYFBBSA-N Bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
210000004958 Brain cells Anatomy 0.000 description 1
RLXCFCYWFYXTON-JTTSDREOSA-N C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(OC(=O)NCCCCCC)[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(OC(=O)NCCCCCC)[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RLXCFCYWFYXTON-JTTSDREOSA-N 0.000 description 1
102100008304 CASS4 Human genes 0.000 description 1
101700032096 CASS4 Proteins 0.000 description 1
125000006519 CCH3 Chemical group 0.000 description 1
ZMANZCXQSJIPKH-UHFFFAOYSA-O CC[NH+](CC)CC Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
102100016494 CD36 Human genes 0.000 description 1
108050003770 CD36 Proteins 0.000 description 1
108010045374 CD36 Antigens Proteins 0.000 description 1
210000003996 CFU-GM Anatomy 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-L CHEBI:8154 Chemical class [O-]P([O-])=O ABLZXFCXXLZCGV-UHFFFAOYSA-L 0.000 description 1
102100002212 CXCR4 Human genes 0.000 description 1
101710003734 CXCR4 Proteins 0.000 description 1
101710036491 CYP26A1 Proteins 0.000 description 1
241000589875 Campylobacter jejuni Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
102000003727 Caveolin-1 Human genes 0.000 description 1
108090000026 Caveolin-1 Proteins 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
210000004671 Cell-Free System Anatomy 0.000 description 1
229940107161 Cholesterol Drugs 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N Cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
239000004380 Cholic acid Substances 0.000 description 1
108090000059 Complement Factor D Proteins 0.000 description 1
102000003706 Complement Factor D Human genes 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108020004394 Complementary RNA Proteins 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
210000000805 Cytoplasm Anatomy 0.000 description 1
210000000172 Cytosol Anatomy 0.000 description 1
FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
238000010442 DNA editing Methods 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
101700070526 DNMT1 Proteins 0.000 description 1
102100018208 DNMT1 Human genes 0.000 description 1
101710038366 DNMT3B Proteins 0.000 description 1
102100015153 DNMT3B Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
ASJSAQIRZKANQN-CRCLSJGQSA-N Deoxyribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
229950006137 Dexfosfoserine Drugs 0.000 description 1
206010012601 Diabetes mellitus Diseases 0.000 description 1
241000255925 Diptera Species 0.000 description 1
230000036947 Dissociation constant Effects 0.000 description 1
229960003722 Doxycycline Drugs 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
108010008814 Drosophila Antp protein Proteins 0.000 description 1
241000255601 Drosophila melanogaster Species 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
108090000799 EC 2.7.11.14 Proteins 0.000 description 1
230000035695 Efflux Effects 0.000 description 1
URLZCHNOLZSCCA-VABKMULXSA-N Enkephalin L Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
230000036826 Excretion Effects 0.000 description 1
210000001723 Extracellular Space Anatomy 0.000 description 1
101700078903 FLP Proteins 0.000 description 1
241000605896 Fibrobacter succinogenes Species 0.000 description 1
241000604777 Flavobacterium columnare Species 0.000 description 1
229940014144 Folate Drugs 0.000 description 1
241000589602 Francisella tularensis Species 0.000 description 1
241000589599 Francisella tularensis subsp. novicida Species 0.000 description 1
108091004285 G-Protein-Coupled Receptor Kinase 1 Proteins 0.000 description 1
101700054531 GDF3 Proteins 0.000 description 1
102100003278 GDF3 Human genes 0.000 description 1
102100008853 GRK7 Human genes 0.000 description 1
241000968725 Gammaproteobacteria bacterium Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 1
108010084340 Gonadotropin-Releasing Hormone Proteins 0.000 description 1
RQFCJASXJCIDSX-UUOKFMHZSA-N Guanosine monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
101700021312 H2BS1 Proteins 0.000 description 1
102100002658 H2BS1 Human genes 0.000 description 1
101700027355 HES1 Proteins 0.000 description 1
102100004111 HES1 Human genes 0.000 description 1
101700031714 HES2 Proteins 0.000 description 1
101700074696 HES3 Proteins 0.000 description 1
101700066574 HES5 Proteins 0.000 description 1
208000005721 HIV Infections Diseases 0.000 description 1
108050008753 HNH endonuclease Proteins 0.000 description 1
102000000310 HNH endonuclease Human genes 0.000 description 1
101700061835 HSF1 Proteins 0.000 description 1
102100003632 HSF1 Human genes 0.000 description 1
101710002907 HSFA1A Proteins 0.000 description 1
101710004114 HSFB2A Proteins 0.000 description 1
230000036499 Half live Effects 0.000 description 1
210000003494 Hepatocytes Anatomy 0.000 description 1
102000006301 Human Immunodeficiency Virus-1 rev protein Human genes 0.000 description 1
108010058443 Human Immunodeficiency Virus-1 rev protein Proteins 0.000 description 1
208000006572 Human Influenza Diseases 0.000 description 1
229940045644 Human calcitonin Drugs 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
229960000310 ISOLEUCINE Drugs 0.000 description 1
206010022000 Influenza Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
210000000936 Intestines Anatomy 0.000 description 1
210000003093 Intracellular Space Anatomy 0.000 description 1
210000004153 Islets of Langerhans Anatomy 0.000 description 1
102100006525 KLF4 Human genes 0.000 description 1
101700048573 KLF4 Proteins 0.000 description 1
102100011311 KNG1 Human genes 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
101700071170 LEF-3 Proteins 0.000 description 1
101710032940 LIN28A Proteins 0.000 description 1
241000186606 Lactobacillus gasseri Species 0.000 description 1
241000186869 Lactobacillus salivarius Species 0.000 description 1
GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
241000283953 Lagomorpha Species 0.000 description 1
229940115932 Legionella pneumophila Drugs 0.000 description 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N Leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
102000016267 Leptin Human genes 0.000 description 1
108010092277 Leptin Proteins 0.000 description 1
210000000265 Leukocytes Anatomy 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
210000004185 Liver Anatomy 0.000 description 1
108020005198 Long Noncoding RNA Proteins 0.000 description 1
101710029649 MDV043 Proteins 0.000 description 1
101710042575 MYB124 Proteins 0.000 description 1
102100015262 MYC Human genes 0.000 description 1
102100000921 MYL2 Human genes 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
230000036740 Metabolism Effects 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
241000713333 Mouse mammary tumor virus Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000202942 Mycoplasma synoviae Species 0.000 description 1
235000009421 Myristica fragrans Nutrition 0.000 description 1
SKVWSNOLUIYQFD-YQUYJWMZSA-N N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6S)-6-[(2R,3S,4R,5R,6R)-6-[(E,2S,3R)-2-formamido-3-hydroxyoctadec-4-enoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxa Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC=O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](O)[C@@H](CO)O3)NC(C)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 SKVWSNOLUIYQFD-YQUYJWMZSA-N 0.000 description 1
229920002957 Naked DNA Polymers 0.000 description 1
229940052778 Neisseria meningitidis Drugs 0.000 description 1
108020004485 Nonsense Codon Proteins 0.000 description 1
210000001623 Nucleosomes Anatomy 0.000 description 1
108010047956 Nucleosomes Proteins 0.000 description 1
DCWXELXMIBXGTH-UHFFFAOYSA-N O(4)-phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
108010077991 O-GlcNAc transferase Proteins 0.000 description 1
102000005520 O-GlcNAc transferase Human genes 0.000 description 1
USRGIUJOYOXOQJ-GBXIJSLDSA-N O-phospho-L-threonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
229910004679 ONO2 Inorganic materials 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102100019163 POU5F1 Human genes 0.000 description 1
101710026246 POU5F1 Proteins 0.000 description 1
LPXQRXLUHJKZIE-UHFFFAOYSA-N Pathocidin Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
108091005771 Peptidases Proteins 0.000 description 1
108010043958 Peptoids Proteins 0.000 description 1
241000577979 Peromyscus spicilegus Species 0.000 description 1
RDOWQLZANAYVLL-UHFFFAOYSA-N Phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical compound C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
WJFKNYWRSNBZNX-UHFFFAOYSA-N Phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
229950000688 Phenothiazine Drugs 0.000 description 1
TZMSYXZUNZXBOL-UHFFFAOYSA-N Phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
229960005190 Phenylalanine Drugs 0.000 description 1
229940067631 Phospholipids Drugs 0.000 description 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N Phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
229960000502 Poloxamer Drugs 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
241001417524 Pomacanthidae Species 0.000 description 1
XJMOSONTPMZWPB-UHFFFAOYSA-M Propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108060006633 Protein Kinases Proteins 0.000 description 1
101700079116 QSOX1 Proteins 0.000 description 1
101700054624 RF1 Proteins 0.000 description 1
102000020497 RNA-Binding Proteins Human genes 0.000 description 1
108091022184 RNA-Binding Proteins Proteins 0.000 description 1
229920001186 RNA-Seq Polymers 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000007156 Resistin Human genes 0.000 description 1
108010047909 Resistin Proteins 0.000 description 1
208000007014 Retinitis Pigmentosa Diseases 0.000 description 1
102000004330 Rhodopsin Human genes 0.000 description 1
108090000820 Rhodopsin Proteins 0.000 description 1
229920001914 Ribonucleotide Polymers 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
102000035266 SCARB3 Human genes 0.000 description 1
101710019780 SLC22A3 Proteins 0.000 description 1
102100017688 SMTN Human genes 0.000 description 1
101700060826 SMTN Proteins 0.000 description 1
102100018829 SOX2 Human genes 0.000 description 1
101700009501 SSB Proteins 0.000 description 1
102100016712 SSB Human genes 0.000 description 1
101700040489 SSB2 Proteins 0.000 description 1
101700058838 SSBP1 Proteins 0.000 description 1
235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
229940081969 Saccharomyces cerevisiae Drugs 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
229920001533 Single-stranded nucleotide Polymers 0.000 description 1
210000003491 Skin Anatomy 0.000 description 1
108020003224 Small Nucleolar RNA Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
210000000952 Spleen Anatomy 0.000 description 1
241001134656 Staphylococcus lugdunensis Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
210000002784 Stomach Anatomy 0.000 description 1
241000194026 Streptococcus gordonii Species 0.000 description 1
102000018075 Subfamily B ATP Binding Cassette Transporter Human genes 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
102000001435 Synapsin Human genes 0.000 description 1
108050009621 Synapsin Proteins 0.000 description 1
210000001744 T-Lymphocytes Anatomy 0.000 description 1
108010076818 TEV protease Proteins 0.000 description 1
101700026084 THY1 Proteins 0.000 description 1
108060008443 TPPP Proteins 0.000 description 1
229920003003 Telomeric non-coding RNA Polymers 0.000 description 1
206010043276 Teratoma Diseases 0.000 description 1
ZEMGGZBWXRYJHK-UHFFFAOYSA-N Thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
229940104230 Thymidine Drugs 0.000 description 1
241000723792 Tobacco etch virus Species 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
PBKWZFANFUTEPS-CWUSWOHSSA-N Transportan Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CC=C(O)C=C1 PBKWZFANFUTEPS-CWUSWOHSSA-N 0.000 description 1
241000589892 Treponema denticola Species 0.000 description 1
102000013534 Troponin C Human genes 0.000 description 1
108010065978 Troponin C Proteins 0.000 description 1
102000031061 Tyrosine 3-monooxygenases Human genes 0.000 description 1
108091000118 Tyrosine 3-monooxygenases Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
102000016350 Viral Proteins Human genes 0.000 description 1
108060009497 WRNexo Proteins 0.000 description 1
241000605939 Wolinella succinogenes Species 0.000 description 1
101700068938 ZFP42 Proteins 0.000 description 1
102100018570 ZFP42 Human genes 0.000 description 1
108010017070 Zinc Finger Nucleases Proteins 0.000 description 1
241001531188 [Eubacterium] rectale Species 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
XVIYCJDWYLJQBG-UHFFFAOYSA-N acetic acid;adamantane Chemical compound CC(O)=O.C1C(C2)CC3CC1CC2C3 XVIYCJDWYLJQBG-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
238000007792 addition Methods 0.000 description 1
230000001058 adult Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
125000002877 alkyl aryl group Chemical group 0.000 description 1
125000005600 alkyl phosphonate group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
125000005122 aminoalkylamino group Chemical group 0.000 description 1
239000003708 ampul Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000003078 antioxidant Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000002617 apheresis Methods 0.000 description 1
238000000149 argon plasma sintering Methods 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
239000008228 bacteriostatic water for injection Substances 0.000 description 1
125000002619 bicyclic group Chemical group 0.000 description 1
102000024070 binding proteins Human genes 0.000 description 1
108091007650 binding proteins Proteins 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000000903 blocking Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000002449 bone cell Anatomy 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
238000004422 calculation algorithm Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
125000001369 canonical nucleoside group Chemical group 0.000 description 1
239000002775 capsule Substances 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
101700056051 cas9 Proteins 0.000 description 1
239000002458 cell surface marker Substances 0.000 description 1
229920002083 cellular DNA Polymers 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
150000001841 cholesterols Chemical class 0.000 description 1
229960002471 cholic acid Drugs 0.000 description 1
235000019416 cholic acid Nutrition 0.000 description 1
238000002983 circular dichroism Methods 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
239000008119 colloidal silica Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
239000008139 complexing agent Substances 0.000 description 1
230000002596 correlated Effects 0.000 description 1
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
235000001671 coumarin Nutrition 0.000 description 1
125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
238000010192 crystallographic characterization Methods 0.000 description 1
125000001651 cyanato group Chemical group [*]OC#N 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
150000001945 cysteines Chemical class 0.000 description 1
230000021953 cytokinesis Effects 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000017858 demethylation Effects 0.000 description 1
238000010520 demethylation reaction Methods 0.000 description 1
239000000412 dendrimer Substances 0.000 description 1
229920000736 dendritic polymer Polymers 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000009795 derivation Methods 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
230000001809 detectable Effects 0.000 description 1
230000001627 detrimental Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
ANCLJVISBRWUTR-UHFFFAOYSA-M diaminophosphinate Chemical compound NP(N)([O-])=O ANCLJVISBRWUTR-UHFFFAOYSA-M 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical class [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
210000001840 diploid cell Anatomy 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 description 1
230000000467 effect on cytodieresis Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
230000000021 endosomolytic Effects 0.000 description 1
230000003511 endothelial Effects 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
230000001973 epigenetic Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000002270 exclusion chromatography Methods 0.000 description 1
230000029142 excretion Effects 0.000 description 1
230000001036 exonucleolytic Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012014 frustrated Lewis pair Substances 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037240 fusion proteins Human genes 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
101710028401 gene 5 Proteins 0.000 description 1
238000003198 gene knock in Methods 0.000 description 1
238000003197 gene knockdown Methods 0.000 description 1
238000003209 gene knockout Methods 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
238000007429 general method Methods 0.000 description 1
244000037671 genetically modified crops Species 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
125000003827 glycol group Chemical group 0.000 description 1
230000001279 glycosylating Effects 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
239000008187 granular material Substances 0.000 description 1
108060003411 grpe Proteins 0.000 description 1
235000013928 guanylic acid Nutrition 0.000 description 1
230000003394 haemopoietic Effects 0.000 description 1
210000003783 haploid cell Anatomy 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
238000003505 heat denaturation Methods 0.000 description 1
125000000592 heterocycloalkyl group Chemical group 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
150000002411 histidines Chemical class 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
101500011263 human Calcitonin Proteins 0.000 description 1
201000001820 human immunodeficiency virus infectious disease Diseases 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000003116 impacting Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000002458 infectious Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
239000003978 infusion fluid Substances 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000000977 initiatory Effects 0.000 description 1
150000002484 inorganic compounds Chemical class 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
239000000138 intercalating agent Substances 0.000 description 1
230000000968 intestinal Effects 0.000 description 1
238000007917 intracranial administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000005304 joining Methods 0.000 description 1
230000000366 juvenile Effects 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
238000011031 large scale production Methods 0.000 description 1
229940039781 leptin Drugs 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal Effects 0.000 description 1
150000002617 leukotrienes Chemical class 0.000 description 1
230000004301 light adaptation Effects 0.000 description 1
230000004807 localization Effects 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
239000001115 mace Substances 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000007885 magnetic separation Methods 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
239000011572 manganese Substances 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
241001515942 marmosets Species 0.000 description 1
238000002844 melting Methods 0.000 description 1
229920002106 messenger RNA Polymers 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000035786 metabolism Effects 0.000 description 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000000693 micelle Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
108091005593 modified peptides Proteins 0.000 description 1
210000000663 muscle cells Anatomy 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
108010065781 myosin light chain 2 Proteins 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
125000001893 nitrooxy group Chemical group [O-][N+](=O)O* 0.000 description 1
229920001894 non-coding RNA Polymers 0.000 description 1
239000011824 nuclear material Substances 0.000 description 1
108010038765 octaarginine Proteins 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000002674 ointment Substances 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
230000003204 osmotic Effects 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
125000004430 oxygen atoms Chemical group O* 0.000 description 1
239000003002 pH adjusting agent Substances 0.000 description 1
101710031992 pRL90232 Proteins 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000004091 panning Methods 0.000 description 1
230000036961 partial Effects 0.000 description 1
230000001717 pathogenic Effects 0.000 description 1
244000052769 pathogens Species 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
108010043655 penetratin Proteins 0.000 description 1
230000000149 penetrating Effects 0.000 description 1
ONTNXMBMXUNDBF-UHFFFAOYSA-N pentatriacontane-17,18,19-triol Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)C(O)CCCCCCCCCCCCCCCC ONTNXMBMXUNDBF-UHFFFAOYSA-N 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
150000002991 phenoxazines Chemical class 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
150000008299 phosphorodiamidates Chemical class 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
101710035540 plaa2 Proteins 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
108060002324 polC Proteins 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
230000003389 potentiating Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000002062 proliferating Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000001902 propagating Effects 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
102000021339 protein binding proteins Human genes 0.000 description 1
108091010288 protein binding proteins Proteins 0.000 description 1
238000001814 protein method Methods 0.000 description 1
FAUKQZGBHAOERC-UHFFFAOYSA-N pyridin-2-amine;1H-pyridin-2-one Chemical compound NC1=CC=CC=N1.O=C1C=CC=CN1 FAUKQZGBHAOERC-UHFFFAOYSA-N 0.000 description 1
UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
RXTQGIIIYVEHBN-UHFFFAOYSA-N pyrimido[4,5-b]indol-2-one Chemical compound C1=CC=CC2=NC3=NC(=O)N=CC3=C21 RXTQGIIIYVEHBN-UHFFFAOYSA-N 0.000 description 1
SRBUGYKMBLUTIS-UHFFFAOYSA-N pyrrolo[2,3-d]pyrimidin-2-one Chemical compound O=C1N=CC2=CC=NC2=N1 SRBUGYKMBLUTIS-UHFFFAOYSA-N 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
230000001603 reducing Effects 0.000 description 1
210000003289 regulatory T cell Anatomy 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained Effects 0.000 description 1
230000002441 reversible Effects 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
238000003559 rna-seq method Methods 0.000 description 1
102220199012 rs369823958 Human genes 0.000 description 1
102220278924 rs864622656 Human genes 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
101700066475 set1 Proteins 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
230000003007 single stranded DNA break Effects 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
210000004215 spores Anatomy 0.000 description 1
101700016657 ssb1 Proteins 0.000 description 1
101700008322 ssbF Proteins 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
REYJJPSVUYRZGE-UHFFFAOYSA-N stearylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
238000011146 sterile filtration Methods 0.000 description 1
231100000803 sterility Toxicity 0.000 description 1
230000035882 stress Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical group NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
150000003456 sulfonamides Chemical group 0.000 description 1
150000003457 sulfones Chemical group 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000003239 susceptibility assay Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002459 sustained Effects 0.000 description 1
235000019527 sweetened beverage Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
108010022344 tat peptide (49-57), Human immunodeficiency virus 1 Proteins 0.000 description 1
239000003491 tear gas Substances 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
230000002588 toxic Effects 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
230000001052 transient Effects 0.000 description 1
108010062760 transportan Proteins 0.000 description 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
238000004450 types of analysis Methods 0.000 description 1
125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
230000002227 vasoactive Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
230000035899 viability Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1